{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:04:39Z","timestamp":1776488679965,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["12-04-91450-NIH"],"award-info":[{"award-number":["12-04-91450-NIH"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006366","name":"Minist\u00e9rio da Educa\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.antiviral.2014.06.019","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T17:48:04Z","timestamp":1404755284000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A new antiviral: Chimeric 3TC\u2013AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo"],"prefix":"10.1016","volume":"109","author":[{"given":"Christophe","family":"Vanpouille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Khandazhinskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Karpenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Zicari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Barreto-de-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Frolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Kochetkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.06.019_b0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/1389200033489253","article-title":"Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist","volume":"4","author":"Beaumont","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.antiviral.2014.06.019_b0010","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2174\/1568026033451763","article-title":"Strategies in the design of prodrugs of anti-HIV agents","volume":"3","author":"Calogeropoulou","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.06.019_b0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(99)80020-8","article-title":"Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion","volume":"30","author":"Chariot","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.06.019_b0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0925-4439(02)00089-3","article-title":"New developments in anti-HIV chemotherapy","volume":"1587","author":"De Clercq","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2014.06.019_b0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2014.06.019_b0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.06.019_b0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nprot.2008.245","article-title":"Use of human tissue explants to study human infectious agents","volume":"4","author":"Grivel","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2014.06.019_b0040","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1073\/pnas.89.5.1934","article-title":"Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine","volume":"89","author":"Kellam","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2014.06.019_b0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1517\/17425251003713501","article-title":"Anti-HIV therapy with AZT prodrugs: AZT phosphonate derivatives, current state and prospects","volume":"6","author":"Khandazhinskaya","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.antiviral.2014.06.019_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1747-0285.2011.01129.x","article-title":"5\u2032-phosphonate derivatives of 2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine as new anti-HIV prodrugs","volume":"78","author":"Khandazhinskaya","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2014.06.019_b0055","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1080\/15257770008045461","article-title":"P-(alkyl)-nucleoside 5\u2032-hydrogenphosphonates as depot forms of antiviral nucleotide analogues","volume":"19","author":"Khandazhinskaya","year":"2000","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.antiviral.2014.06.019_b0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/dmd.108.022269","article-title":"5\u2032-aminocarbonyl phosphonates as new zidovudine depot forms: antiviral properties, intracellular transformations, and pharmacokinetic parameters","volume":"37","author":"Khandazhinskaya","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2014.06.019_b0065","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1081\/NCN-120022675","article-title":"Synthesis of certain heterodimers expected as HIV-1 reverse transcriptase inhibitors","volume":"22","author":"Laduree","year":"2003","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.antiviral.2014.06.019_b0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2008.07.008","article-title":"Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues","volume":"4","author":"Lisco","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2014.06.019_b0075","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1021\/jm991125l","article-title":"Synthesis and evaluation of \u201cAZT-HEPT\u201d, \u201cAZT-pyridinone\u201d, and \u201cddC-HEPT\u201d conjugates as inhibitors of HIV reverse transcriptase","volume":"43","author":"Pontikis","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.06.019_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-3542(90)90062-C","article-title":"Synthesis and biological evaluation of dinucleoside methylphosphonates of 3\u2032-azido-3\u2032-deoxythymidine and 2\u2032, 3\u2032-dideoxycytidine","volume":"14","author":"Puech","year":"1990","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.06.019_b0085","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.95.16.9518","article-title":"3\u2032-Azido-3\u2032-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes","volume":"95","author":"Ren","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2014.06.019_b0090","doi-asserted-by":"crossref","first-page":"e9310","DOI":"10.1371\/journal.pone.0009310","article-title":"In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide","volume":"5","author":"Rohan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.06.019_b0095","first-page":"599","article-title":"Prodrugs and soft drugs","volume":"58","author":"Stanczak","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.antiviral.2014.06.019_b0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tim.2012.05.005","article-title":"Microbicides: still a long road to success","volume":"20","author":"Vanpouille","year":"2012","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2014.06.019_b0105","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1021\/jm00010a008","article-title":"Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase","volume":"38","author":"Velazquez","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.06.019_b0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1368-7646(98)80025-3","article-title":"HIV resistance to antiviral drugs: public health implications","volume":"1","author":"Wainberg","year":"1998","journal-title":"Drug Resist. Updat."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:42Z","timestamp":1759062402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214001818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":22,"alternative-id":["S0166354214001818"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.06.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new antiviral: Chimeric 3TC\u2013AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}